Aerospace · NYSE: RTX
RTX earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends December · next results expected around 26 Jan 2027
Latest: Q3 2026
RTX reported Q3 2026 sales of $25.0 billion, up 11 percent versus prior year, with GAAP EPS of $1.89 and adjusted EPS of $2.26, up 33 percent.
RTX grew sales 11 percent to $24,965 million in the third quarter, or 12 percent excluding acquisitions, divestitures and currency. All three segments grew, led by Raytheon at 14 percent. Adjusted EPS rose to $2.26, including $0.25 from recovery of IEEPA tariff costs. Backlog reached a record $340 billion after large Tomahawk and AMRAAM munitions contracts. Pratt & Whitney took a $363 million customer bankruptcy charge.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $21.6B * |
| Q1 2025 | $20.3B |
| Q2 2025 | $21.6B |
| Q3 2025 | $22.5B |
| Q4 2025 | $24.2B * |
| Q1 2026 | $22.1B |
| Q2 2026 | $24.7B |
| Q3 2026 | $25.0B |
Data
| Q1 2025 | $1.14 |
| Q2 2025 | $1.22 |
| Q3 2025 | $1.41 |
| Q1 2026 | $1.51 |
| Q2 2026 | $1.57 |
| Q3 2026 | $1.89 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | 9.8% |
| Q1 2025 | 10.0% |
| Q2 2025 | 9.9% |
| Q3 2025 | 11.2% |
| Q4 2025 | 10.7% |
| Q1 2026 | 11.6% |
| Q2 2026 | 11.4% |
| Q3 2026 | 13.4% |
Data
| Q4 2024 | $492.0M |
| Q1 2025 | $792.0M |
| Q2 2025 | -$72.0M |
| Q3 2025 | $4.0B |
| Q4 2025 | $3.2B |
| Q1 2026 | $1.3B |
| Q2 2026 | $2.9B |
| Q3 2026 | $2.1B |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.6Bd | $20.3B | $21.6B | $22.5B | $24.2Bd | $22.1B | $24.7B | $25.0B |
| Operating income | $2.1Bd | $2.0B | $2.1B | $2.5B | $2.6Bd | $2.6B | $2.8B | $3.3B |
| Operating margin | 9.8% | 10.0% | 9.9% | 11.2% | 10.7% | 11.6% | 11.4% | 13.4% |
| Net income | $1.5Bd | $1.5B | $1.7B | $1.9B | $1.6Bd | $2.1B | $2.1B | $2.6B |
| Diluted EPS | — | $1.14 | $1.22 | $1.41 | — | $1.51 | $1.57 | $1.89 |
| Operating cash flow | $1.6Bd | $1.3B | $458.0Md | $4.6Bd | $4.2Bd | $1.9B | $3.5Bd | $2.9Bd |
| Capital expenditure | $1.1Bd | $513.0M | $530.0Md | $614.0Md | $970.0Md | $546.0M | $669.0Md | $749.0Md |
| Free cash flow | $492.0M | $792.0M | -$72.0M | $4.0B | $3.2B | $1.3B | $2.9B | $2.1B |
| R&D expense | $808.0Md | $637.0M | $697.0M | $684.0M | $789.0Md | $627.0M | $726.0M | $711.0M |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-Q and 10-K filings
- 20 Oct 202610-Q for the period ended 30 Sep 2026SEC ↗
- 23 Jul 202610-Q for the period ended 30 Jun 2026SEC ↗
- 21 Apr 202610-Q for the period ended 31 Mar 2026SEC ↗
- 6 Feb 202610-K for the period ended 31 Dec 2025SEC ↗
- 21 Oct 202510-Q for the period ended 30 Sep 2025SEC ↗
- 22 Jul 202510-Q for the period ended 30 Jun 2025SEC ↗
- 22 Apr 202510-Q for the period ended 31 Mar 2025SEC ↗
- 3 Feb 202510-K for the period ended 31 Dec 2024SEC ↗